US$ 28.57
foxo4-dri human clinical trial peptide senolytic Molecular modelling of the FOXO4-TP53 interaction to design senolytic FOXO4-DRI 10mg | PeptideX Research
Description
Parkhitko, A

worked with daily injections of 50 mg (which are extremely high doses)

We look at the patients goals, medical background, and realistic next steps before making recommendations. Karla K

0.3 mL Syringe(showing per shot 2 shots total) 25 IU Tips & Notes Mechanism 5-Amino-1MQ inhibits NNMT, an enzyme overexpressed in fat tissue

That matters because trial populations differ
